Efficacy and safety of cemdisiran siRNA in myasthenia gravis (NIMBLE): a double-blind, randomised, placebo-controlled, phase 3 trial. (linkinghub.elsevier.com)

Authors: Vu T … Howard JF Jr Journal: The Lancet Published: 2026-05-02 DOI: https://doi.org/10.1016/S0140-6736(26)00690-2